2-Methyl-2-propanyl 3-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1-azetidinecarboxylate(CAS: 877399-31-0)

This compound (CAS: 877399-31-0) falls under various regulatory guidelines such as GHS (Globally Harmonized System of Classification and Labelling of Chemicals) for classification and labelling. It may also be subject to REACH regulations for its production and import in the European Union. In the United States, it may be regulated by the FDA for pharmaceutical applications and the EPA for environmental safety. Specific requirements should be checked based on the intended use and jurisdiction.

There are several alternatives to this compound in synthesis, including other azetidine derivatives and pyrazole analogs. Common alternatives include different boronic acids and esters, which may offer similar functionalities with varying reactivity and synthetic routes. Consulting chemical databases and literature can provide a comprehensive list of viable alternatives.

Research trends for this compound (CAS: 877399-31-0) are increasingly focused on its use in medicinal chemistry, particularly in developing new drug candidates. Market trends suggest growing interest in its potential as a scaffold for drug discovery. The compound is also being explored in academic settings for its unique chemical properties and potential applications in organic synthesis.

Waste containing this compound (CAS: 877399-31-0) should be collected in a sealed container and disposed of through a professional hazardous waste disposal service. Incineration is a common method for disposal, but it should be conducted in an appropriate industrial facility to minimize environmental impact. Ensure all safety precautions are followed and consult local regulations for specific disposal requirements.